The global hysterectomy device market was valued at $328.09 million in 2021 and is projected to reach $566.5 million by 2031, registering a CAGR of 5.63% from 2022 to 2031.
The surgical removal of the uterus and, less frequently, the cervix is known as a hysterectomy. A hysterectomy may involve the removal of nearby organs and tissues, including the ovaries and fallopian tubes, depending on the reason for the surgery. It is typically performed as a treatment for a variety of gynecological conditions, such as uterine fibroids, endometriosis, and abnormal uterine bleeding. Hysterectomy can be performed using a variety of surgical techniques, including open surgery, laparoscopic surgery, and robot-assisted surgery.
The driving factors for hysterectomy device market is rise in prevalence of uterine cancer. Uterine cancer is one of the most common gynecological cancers, and hysterectomy is a common treatment option for this disease. In addition, various government organizations and NGOs are creating awareness among the people about women’s health which also fuels the market growth. Moreover, hysterectomy devices have seen a number of technological advancements in recent years, which have improved surgical outcomes, decreased patient discomfort and recovery time also propels the market growth.
However, factors such as availability of alternative treatment for the treatment of gynecological disorders expected to hinder the growth of hysterectomy device market. On the other hand, a surge in demand for minimally or less invasive surgeries is anticipated to offer growth opportunity for the market.
The global hysterectomy device market is segmented into disease type, surgical approach, end user and region. By disease type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic assisted laparoscopic hysterectomy and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global hysterectomy device market are Conkin surgical instruments ltd, Cooper Surgical, B. braun medical ltd, KARL STORZ GmbH & Co. KG, Conmed Corporation, Jhonson & Jhonson, Richard Wolf GmbH, Fortimedix Surgical, Medtronic corporation and Laborie, Inc.
The surgical removal of the uterus and, less frequently, the cervix is known as a hysterectomy. A hysterectomy may involve the removal of nearby organs and tissues, including the ovaries and fallopian tubes, depending on the reason for the surgery. It is typically performed as a treatment for a variety of gynecological conditions, such as uterine fibroids, endometriosis, and abnormal uterine bleeding. Hysterectomy can be performed using a variety of surgical techniques, including open surgery, laparoscopic surgery, and robot-assisted surgery.
The driving factors for hysterectomy device market is rise in prevalence of uterine cancer. Uterine cancer is one of the most common gynecological cancers, and hysterectomy is a common treatment option for this disease. In addition, various government organizations and NGOs are creating awareness among the people about women’s health which also fuels the market growth. Moreover, hysterectomy devices have seen a number of technological advancements in recent years, which have improved surgical outcomes, decreased patient discomfort and recovery time also propels the market growth.
However, factors such as availability of alternative treatment for the treatment of gynecological disorders expected to hinder the growth of hysterectomy device market. On the other hand, a surge in demand for minimally or less invasive surgeries is anticipated to offer growth opportunity for the market.
The global hysterectomy device market is segmented into disease type, surgical approach, end user and region. By disease type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic assisted laparoscopic hysterectomy and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global hysterectomy device market are Conkin surgical instruments ltd, Cooper Surgical, B. braun medical ltd, KARL STORZ GmbH & Co. KG, Conmed Corporation, Jhonson & Jhonson, Richard Wolf GmbH, Fortimedix Surgical, Medtronic corporation and Laborie, Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hysterectomy device market analysis from 2021 to 2031 to identify the prevailing hysterectomy device market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the hysterectomy device market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global hysterectomy device market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly update (only available with the purchase of an enterprise license)
- 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
- Free updated version (once released) with the purchase of a 1-5 or enterprise user license.
- 16 analyst hours of support (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% free customization (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
- Free data pack (Excel version) with the purchase of a 1-5 or enterprise user license.
- Free report update, if the report is 6-12 months old or older.
- 24-hour priority response
- Free industry updates and white papers.
Key Market Segments
By Surgical approach
- Laparoscopic hysterectomy
- Robotic assisted laparoscopic hysterectomy
- Abdominal hysterectomy
- Vaginal hysterectomy
By Disease type
- Uterine Cancer
- Fibroids
- Chronic pelvic pain
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- B. Braun Melsungen AG
- Conkin surgical instruments ltd
- CONMED Corporation
- Cooper Companies, Inc.
- fortimedix surgical b.v.
- Johnson & Johnson
- KARL STORZ GmbH & Co. KG
- Laborie, Inc
- Medtronic plc
- Richard Wolf GmbH
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE
CHAPTER 5: HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH
CHAPTER 6: HYSTERECTOMY DEVICE MARKET, BY END USER
CHAPTER 7: HYSTERECTOMY DEVICE MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to this report, the hysterectomy device market was valued at $328.09 million in 2021, and is estimated to reach $566.5 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031.Hysterectomy device s are used to perform hysterectomy surgeries which involve removal of uterus and around organs due to uterine cancer, fibroids, chronic pelvic pain, uterine prolapse, endometriosis and adenomyosis. These device s are designed to help surgeons safely and effectively remove the uterus and associated tissue while minimizing complications and reducing patient recovery time. A hysterectomy may involve the removal of nearby organs and tissues, including the ovaries and fallopian tubes, depending on the purpose of surgery.
Key factors driving the growth of the hysterectomy device market include rise in prevalence of cancer disease especially uterine cancer led to increases the number of patients who needs a diagnosis and treatment which increased the adoption of hysterectomy procedure for treatment purpose supports the market growth. The most prevalent type of gynecological cancer, uterine cancer, affects women of all ages. Uterine cancer risk rises with age, and women over 50 are more likely to be diagnosed with the condition.
Hysterectomy is also used to treat other gynecologic disorders like endometriosis, uterine fibroids, and irregular uterine bleeding in addition to uterine cancer. Moreover rising prevalence of fibroids and demand for hysterectomy for treatment of the fibroids propels the market growth. For an instance, according to the U. S. Department of the Health & Human Services More than 200,000 hysterectomies are performed each year for uterine fibroids.
In addition, growing awareness of women's health is one of the key drivers of the hysterectomy devices market. Various organizations are carrying out campaigns to rise awareness among women related to gynecological health. Furthermore, the market for hysterectomy devices has grown significantly owing to technological improvements. The procedure is now less invasive and has a shorter recovery period because of advances in minimally invasive surgical procedures including laparoscopic and robot-assisted hysterectomy. Moreover, the market for hysterectomy devices is expected to grow during the forecast period as a result of the rising focus on women's health and the availability of more cutting-edge, minimally invasive treatment alternatives.
Some gynecologic diseases can be effectively treated by hysterectomy. It is a significant surgical treatment with potential risks and long-term effects, including menopause and infertility. As a result, the availability of alternative treatments may hinder the market growth for hysterectomy devices as patients choose less invasive procedures like hormone therapy or uterine artery embolization that may also result in quicker recovery times. Conversely, the market is anticipated to experience growth during the forecast period as a result of the rising demand for minimally invasive procedures and robotic-assisted surgeries. Due to their potential advantages, such as shorter hospital stays, less blood loss, and quicker recovery times when compared to conventional open surgery.
The global hysterectomy device market is segmented into disease type, surgical approach, end user and region. By disease type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic assisted laparoscopic hysterectomy and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center and others. Region wise, the market is analyzed across North America (the U. S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key players profiled in the study include Conkin surgical instruments ltd, Cooper Surgical, B. braun medical ltd, KARL STORZ GmbH & Co. KG, Conmed Corporation, Jhonson & Jhonson, Richard Wolf GmbH, Fortimedix Surgical, Medtronic corporation and Laborie, Inc. The players in the market have been actively engaged in the adoption various strategies such as acquisition to remain competitive and gain advantage over the competitors in the market. For instance, in May 2020, in February 2022, Cooper Companies announced it has signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets.
Key Market Insights (Updated)
By disease type, the chronic pelvic pain segment was the largest revenue contributor to the market in 2021. However, the fibroids segment is anticipated to grow at the highest CAGR during the forecast period.
By surgical approach, the abdominal hysterectomy segment dominated the global market in 2021.
Based on end user, the hospital segment was the largest revenue contributor to the market in 2021 and is estimated to reach $261.8 million by 2031, with a CAGR of 5.9%.
Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- B. Braun Melsungen AG
- Conkin surgical instruments ltd
- CONMED Corporation
- Cooper Companies, Inc.
- fortimedix surgical b.v.
- Johnson & Johnson
- KARL STORZ GmbH & Co. KG
- Laborie, Inc
- Medtronic plc
- Richard Wolf GmbH
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
